Investment
Features
FeesSafety
Academy
More
Pluang+

Beasley reports $230M Q4 loss due to FCC license impairment, shifts focus to digital growth and debt reduction.

Company Fundamentals
08 Apr 2026
PRNewsWire
View Source
Bearish
pluang ai news

Beasley Broadcast Group reported a $230 million operating loss in Q4 2025, primarily due to a $224.8 million non-cash impairment charge on FCC licenses amid ongoing challenges in the traditional radio advertising market. Despite revenue falling 21.1% to $53.1 million, digital revenue grew nearly 10% year-over-year, now accounting for 23.7% of net revenue, highlighting the company's strategic shift towards digital platforms. The company also completed asset sales generating $26 million and plans a debt reduction transaction to halve its second lien debt, aiming to strengthen its balance sheet and focus on long-term value creation through digital expansion and cost restructuring.

More News

Barclays raises Hudbay Minerals price target to $32 on strong copper growth outlook.

Barclays raises Hudbay Minerals price target to $32 on strong copper growth outlook.

Barclays increased its price target for Hudbay Minerals to $32 from $30, citing strong growth prospects in copper mining. Despite a recent nearly 30% stock pullback due to market sentiment, Hudbay maintains a solid financial position with near-zero n...

Analyst Insights
Bullish
51 minutes ago
Morgan Stanley beats Q2 earnings and revenue estimates with strong divisional growth.

Morgan Stanley beats Q2 earnings and revenue estimates with strong divisional growth.

Morgan Stanley reported strong Q2 2026 results, with earnings per share of $3.46 surpassing estimates of $2.89 and revenue of $21.35 billion beating forecasts of $19.67 billion. This marks significant year-over-year growth from $16.79 billion, driven...

Company Fundamentals
Bullish
54 minutes ago
Autoimmune therapeutics market to reach $137.85B by 2035, driven by biologics and precision medicine growth

Autoimmune therapeutics market to reach $137.85B by 2035, driven by biologics and precision medicine growth

The global autoimmune disease therapeutics market is projected to grow from $80.54 billion in 2025 to $137.85 billion by 2035, at a CAGR of 5.52%. Growth is fueled by rising autoimmune disease prevalence, advances in biologics, JAK inhibitors, monocl...

Market News
Bullish
54 minutes ago
Light Up Chinatown! 2026 festival returns to Vancouver with food, music, and community events on August 8-9.

Light Up Chinatown! 2026 festival returns to Vancouver with food, music, and community events on August 8-9.

The Vancouver Chinatown Foundation and RBC are hosting Light Up Chinatown! 2026, a free two-day festival on August 8-9 along Columbia Street in Vancouver’s Chinatown. The event features exclusive food collaborations, live music performances, family a...

Others
Neutral
54 minutes ago
Travelers are more strategic with rewards programs, seeking value and ease amid rising loyalty challenges.

Travelers are more strategic with rewards programs, seeking value and ease amid rising loyalty challenges.

New research from iSeatz reveals that U.S. travelers are increasingly strategic about travel rewards programs, with 40% treating them as financial optimization tools and 60% belonging to multiple programs. Despite high enrollment, many travelers find...

Others
Neutral
54 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App